Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Other Non-Current Assets of $3.8 million in Q4 2025, up 10.2% quarter-over-quarter from $3.4 million in Q3 2025, and down 40.16% on a YoY basis from $6.3 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Other Non-Current Assets (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $3.8 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 40.16% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (down 40.16% YoY), while the FY2025 annual figure was $3.3 million, down 42.83% from the prior year.
- Other Non-Current Assets was $3.8 million for Q4 2025 at Prestige Consumer Healthcare, up from $3.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.7 million in Q3 2024 to a low of $2.5 million in Q2 2021.
- Historically, Other Non-Current Assets has averaged $3.9 million across 5 years, with a median of $3.3 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets surged 99.84% in 2023, then plunged 51.48% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $2.9 million in 2021, then increased by 9.13% to $3.2 million in 2022, then soared by 99.84% to $6.3 million in 2023, then grew by 0.57% to $6.3 million in 2024, then slumped by 40.16% to $3.8 million in 2025.
- The last three Other Non-Current Assets figures came in at $3.8 million (Q4 2025), $3.4 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 47.63 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 3.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | 3.27 Mn |
| Dec 31, 2024 | 6.34 Mn |
| Sep 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 6.23 Mn |
| Mar 31, 2024 | 5.73 Mn |
| Dec 31, 2023 | 6.30 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.01 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 2.58 Mn |
| Jun 30, 2022 | 2.74 Mn |
| Mar 31, 2022 | 3.27 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.56 Mn |
| Jun 30, 2021 | 2.52 Mn |
| Mar 31, 2021 | 2.86 Mn |